Hutch News

Hutch News

Stories tagged 'Tumor specific translational research'

Good News at Fred Hutch

Celebrating faculty and staff achievements

Jan. 18, 2018

Three young international investigators working in metastatic breast cancer research at Fred Hutchinson Cancer Research Center recently received postdoctoral fellowships totaling nearly $500,000 — and more good news at Fred Hutch.

View story >


10 highlights of Fred Hutch science in 2017

A look back at notable discoveries in cancer immunotherapy, HIV prevention and more

Dec. 28, 2017 | by Sabin Russell and Susan Keown / Fred Hutch News Service

It's been a year of breakthroughs at Fred Hutch. Here are 10 of our favorites.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

Dec. 14, 2017

Fred Hutchinson Cancer Research Center has announced awards totaling $1 million to nine of its scientists through the Evergreen Fund, a unique grant program that supports homegrown research projects deemed attractive to potential commercial partners. This is the second year of Evergreen Fund awards. This is the second year of Evergreen Fund awards. The Hutch’s Business Development & Strategy office created the program in 2016 in an effort to encourage scientists to pursue creative ideas with commercial appeal. The goal is to speed research from the bench to the bedside while generating income from patent rights and partnerships with the business sector.

View story >


Experimental drug makes some pancreatic cancers more vulnerable to chemo

Early trial shows possibility of knocking down a ‘daunting’ cancer’s defense

Dec. 12, 2017 | by Susan Keown / Fred Hutch News Service

An experimental drug that helps chemo penetrate pancreatic tumors lengthened progression-free survival in a Phase 2 trial.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

Dec. 7, 2017

Fred Hutch Pancreatic cancer researcher Dr. Sunil Hingorani has won a three-year, $1.8 million grant from the federal Cancer Moonshot program, the signature initiative of former Vice President Joseph Biden. Hingorani is one of six collaborators nationwide who received funding this fall for a new research consortium focused on the biological context of pancreatic tumors — such as nearby immune cells or blood vessels — which can have a major impact on a tumor’s vulnerability to treatment.

View story >


Beth Caldwell's impact on metastatic breast cancer

By living — and dying — out loud, @CultPerfectMoms gave a voice to #stage4 that will not be silenced

Nov. 3, 2017 | By Mary Engel / Fred Hutch News Service

Determined that the rest of us pay attention to how urgently we need a cure for metastatic breast cancer, advocate extraordinaire Beth Caldwell lived — and died — with a candor that encompasses grit, grief, swearing, humor and a huge, huge heart.

View story >



GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.